6月24日 香港健谈会活动

On Thursday, 24^th June, from 1:00 pm to 1:50 pm CET (Switzerland Time) 7:00 to 7:50 p.m. (China/HK/SG Time), Basel Healthcare Dialogues (HCD) welcomes Dr. Andree Bates, CEO, Founder of Eularis & AI-cademy, will deliver a talk entitled “Can Pharma and Biotech industries scale new frontiers with AI? How can we differentiate between hype, fiction & facts?"
 
Over the last few years, we have been witnessing the increased use of artificial intelligence in the pharma and biotech industry and redefining how scientists develop new drugs, tackle disease, and so much more.

While the industry continues to acknowledge the importance of AI, how much of that is being translated into practical applications and how? Can AI help accelerate innovation in the industry? Are there any ways to improve patient access to treatment and even improve the predictability of treatment outcomes? Can AI improve the drug discovery and the screening processes? Which companies are the leading AI champions in the industry? What is the next disruptive AI technology? Tune in and listen to this and other insights from Andree Bates.

Places are limited to 100. First come, first served.

Andree Bates Founder of Eularis & AI-cademy PhD in neuroscience & cognitive science. Chairman of the Board, CEO & thought leader, blending cutting-edge healthcare and biopharma AI and Innovation strategy to transform performance. Helps infuse AI into companies for growth.